Advertisement

An Encephalitis Primer

  • Dominic Kelly
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB)

Abstract

For most clinicians managing a patient with encephalitis will be an infrequent event. The range of differential diagnoses in a child presenting with a clinical syndrome that could be encephalitis is broad. In addition, there are many pathogens that can cause encephalitis. In view of these facts, a systematic approach to clinical assessment, investigation and treatment, based on epidemiology and an understanding the limits of investigations, is crucial to effective management of this condition. This review focuses on encephalitis aetiology and investigation; HSV encephalitis; mycoplasma encephalitis; and flavivirus encephalitis as a globally important cause of disease.

Keywords

West Nile Virus Central Nervous System Infection Japanese Encephalitis Viral Encephalitis Intravenous Acyclovir 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Thompson C, Kneen R, Riordan A, Kelly D, Pollard AJ (2012) Encephalitis in children. Arch Dis Child 97(2):150–161PubMedCrossRefGoogle Scholar
  2. 2.
    Long SS (2011) Encephalitis diagnosis and management in the real world. Adv Exp Med Biol 697:153–173PubMedCrossRefGoogle Scholar
  3. 3.
    Tunkel AR, Glaser CA, Bloch KC, Sejvar JJ, Marra CM, Roos KL et al (2008) The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 47(3):303–327PubMedCrossRefGoogle Scholar
  4. 4.
    Kneen R, Michael BD, Menson E, Mehta B, Easton A, Hemingway C et al (2012) National guideline for the management of suspected viral encephalitis in children. J Infect 64(5):449–477Google Scholar
  5. 5.
    Kolski H, Ford-Jones EL, Richardson S, Petric M, Nelson S, Jamieson F et al (1998) Etiology of acute childhood encephalitis at The Hospital for Sick Children, Toronto, 1994–1995. Clin Infect Dis 26(2):398–409PubMedCrossRefGoogle Scholar
  6. 6.
    Glaser CA, Gilliam S, Schnurr D, Forghani B, Honarmand S, Khetsuriani N et al (2003) In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998–2000. Clin Infect Dis 36(6):731–742PubMedCrossRefGoogle Scholar
  7. 7.
    Granerod J, Ambrose HE, Davies NW, Clewley JP, Walsh AL, Morgan D et al (2010) Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 10(12):835–844PubMedCrossRefGoogle Scholar
  8. 8.
    Granerod J, Crowcroft NS (2007) The epidemiology of acute encephalitis. Neuropsychol Rehabil 17(4–5):406–428PubMedCrossRefGoogle Scholar
  9. 9.
    Granerod J, Tam CC, Crowcroft NS, Davies NW, Borchert M, Thomas SL (2010) Challenge of the unknown. A systematic review of acute encephalitis in non-outbreak situations. Neurology 75(10):924–932PubMedCrossRefGoogle Scholar
  10. 10.
    Fowler A, Stodberg T, Eriksson M, Wickstrom R (2008) Childhood encephalitis in Sweden: etiology, clinical presentation and outcome. Eur J Paediatr Neurol 12(6):484–490PubMedCrossRefGoogle Scholar
  11. 11.
    Willoughby RE Jr., Tieves KS, Hoffman GM, Ghanayem NS, Amlie-Lefond CM, Schwabe MJ et al (2005) Survival after treatment of rabies with induction of coma. N Engl J Med 352(24):2508–2514PubMedCrossRefGoogle Scholar
  12. 12.
    Whitley RJ, Alford CA, Hirsch MS, Schooley RT, Luby JP, Aoki FY et al (1986) Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med 314(3):144–149PubMedCrossRefGoogle Scholar
  13. 13.
    Whitley RJ, Kimberlin DW (2005) Herpes simplex encephalitis: children and adolescents. Semin Pediatr Infect Dis 16(1):17–23PubMedCrossRefGoogle Scholar
  14. 14.
    Kimberlin DW, Lin CY, Jacobs RF, Powell DA, Corey L, Gruber WC et al (2001) Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics 108(2):230–238PubMedCrossRefGoogle Scholar
  15. 15.
    De Tiege X, Heron B, Lebon P, Ponsot G, Rozenberg F (2003) Limits of early diagnosis of herpes simplex encephalitis in children: a retrospective study of 38 cases. Clin Infect Dis 36(10):1335–1339PubMedCrossRefGoogle Scholar
  16. 16.
    Baskin HJ, Hedlund G (2007) Neuroimaging of herpesvirus infections in children. Pediatr Radiol 37(10):949–963PubMedCrossRefGoogle Scholar
  17. 17.
    Kelly D, Kroll JS (2004) Encephalitis—beyond aciclovir. Adv Exp Med Biol 549:177–183PubMedCrossRefGoogle Scholar
  18. 18.
    Elbers JM, Bitnun A, Richardson SE, Ford-Jones EL, Tellier R, Wald RM et al (2007) A 12-year prospective study of childhood herpes simplex encephalitis: is there a broader spectrum of disease? Pediatrics 119(2):399–407CrossRefGoogle Scholar
  19. 19.
    Chan PK, Chow PC, Peiris JS, Mak AW, Huen KF (2000) Use of oral valaciclovir in a 12-year-old boy with herpes simplex encephalitis. Hong Kong Med J 6(1):119–121PubMedGoogle Scholar
  20. 20.
    Pouplin T, Pouplin JN, Van Toi P, Lindegardh N, Rogier van Doorn H, Hien TT et al (2011) Valacyclovir for herpes simplex encephalitis. Antimicrob Agents Chemother 55(7):3624–3626PubMedCrossRefGoogle Scholar
  21. 21.
    Musallam B, Matoth I, Wolf DG, Engelhard D, Averbuch D (2007) Steroids for deteriorating herpes simplex virus encephalitis. Pediatr Neurol 37(3):229–232PubMedCrossRefGoogle Scholar
  22. 22.
    Kamei S, Sekizawa T, Shiota H, Mizutani T, Itoyama Y, Takasu T et al (2005) Evaluation of combination therapy using aciclovir and corticosteroid in adult patients with herpes simplex virus encephalitis. J Neurol Neurosurg Psychiatry 76(11):1544–1549PubMedCrossRefGoogle Scholar
  23. 23.
    German Trial of Aciclovir and Corticosteroids in Herpes Simplex Encephalitis (GACHE). http://www.klinikum.uni-heidelberg.de/index.php?id = 4223&L = en
  24. 24.
    Bitnun A, Ford-Jones EL, Petric M, MacGregor D, Heurter H, Nelson S et al (2001) Acute childhood encephalitis and Mycoplasma pneumoniae. Clin Infect Dis 32(12):1674–1684PubMedCrossRefGoogle Scholar
  25. 25.
    Koskiniemi M, Vaheri A (1989) Effect of measles, mumps, rubella vaccination on pattern of encephalitis in children. Lancet 1(8628):31–34PubMedCrossRefGoogle Scholar
  26. 26.
    Bitnun A, Richardson SE (2010) Mycoplasma pneumoniae: Innocent Bystander or a True Cause of Central Nervous System Disease? Curr Infect Dis Rep 12(4):282–290PubMedCrossRefGoogle Scholar
  27. 27.
    Tong CY, Menson E, Lin JP, Lim M (2011) Prevalence of mycoplasma encephalitis. Lancet Infect Dis 11(6):425–426PubMedCrossRefGoogle Scholar
  28. 28.
    Narita M (2009) Pathogenesis of neurologic manifestations of Mycoplasma pneumoniae infection. Pediatr Neurol 41(3):159–166PubMedCrossRefGoogle Scholar
  29. 29.
    Jaruratanasirikul S, Hortiwakul R, Tantisarasart T, Phuenpathom N, Tussanasunthornwong S (1996) Distribution of azithromycin into brain tissue, cerebrospinal fluid, and aqueous humor of the eye. Antimicrob Agents Chemother 40(3):825–826PubMedGoogle Scholar
  30. 30.
    Esposito S, Tagliabue C, Bosis S, Principi N (2011) Levofloxacin for the treatment of Mycoplasma pneumoniae-associated meningoencephalitis in childhood. Int J Antimicrob Agents 37(5):472–475PubMedCrossRefGoogle Scholar
  31. 31.
    Solomon T (2004) Flavivirus encephalitis. N Engl J Med 351(4):370–378PubMedCrossRefGoogle Scholar
  32. 32.
    Campbell GL, Hills SL, Fischer M, Jacobson JA, Hoke CH, Hombach JM et al (2011) Estimated global incidence of Japanese encephalitis: a systematic review. Bull World Health Organ 89(10):766–774, 74A–74EPubMedCrossRefGoogle Scholar
  33. 33.
    Hoke CH Jr., Vaughn DW, Nisalak A, Intralawan P, Poolsuppasit S, Jongsawas V et al (1992) Effect of high-dose dexamethasone on the outcome of acute encephalitis due to Japanese encephalitis virus. J Infect Dis 165(4):631–637PubMedCrossRefGoogle Scholar
  34. 34.
    Solomon T, Dung NM, Wills B, Kneen R, Gainsborough M, Diet TV et al (2003) Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial. Lancet 361(9360):821–826PubMedCrossRefGoogle Scholar
  35. 35.
    Murray KO, Mertens E, Despres P (2010) West Nile virus and its emergence in the United States of America. Vet Res 41(6):67PubMedCrossRefGoogle Scholar
  36. 36.
    Jackson AC (2004) Therapy of West Nile virus infection. Can J Neurol Sci 31(2):131–134PubMedGoogle Scholar
  37. 37.
    Mansfield KL, Johnson N, Phipps LP, Stephenson JR, Fooks AR, Solomon T (2009) Tick-borne encephalitis virus—a review of an emerging zoonosis. J Gen Virol 90(Pt 8):1781–1794PubMedCrossRefGoogle Scholar
  38. 38.
    HPA (2011) Louping ill. 2011 (cited 15 Jan 2012). http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/LoupingIll/Google Scholar
  39. 39.
    Guffond T, Dewilde A, Lobert PE, Lefebvre DC, Hober D, Wattre P (1994) Significance and Clinical Relevance of the Detection of Herpes-Simplex Virus-DNA by the Polymerase Chain-Reaction in Cerebrospinal-Fluid from Patients with Presumed Encephalitis. Clin Infect Dis 18(5):744–749PubMedCrossRefGoogle Scholar
  40. 40.
    Studahl M, Bergstrom T, Hagberg L (1998) Acute viral encephalitis in adults—a prospective study. Scand J Infect Dis 30(3):215–220PubMedCrossRefGoogle Scholar
  41. 41.
    Weil AA, Glaser CA, Amad Z, Forghani B (2002) Patients with suspected herpes simplex encephalitis: rethinking an initial negative polymerase chain reaction result. Clin Infect Dis 34(8):1154–1157PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Children’s HospitalOxfordUK

Personalised recommendations